Category: news

Life Sciences Executive Michael P. Gray Brings Strong Background in Biotechnology Capital Markets, Business Operations, Business Development and Alliance Management…

– Company advances NT-0167 as first development candidate from a broad platform of NLRP3 inflammasome inhibitors – – Appoints Don…

AMSTERDAM–(BUSINESS WIRE)–Synaffix B.V., a Dutch biotechnology company exclusively focused on continued advancement of its clinical-stage antibody-drug conjugate (ADC) technology for…

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has entered into a new $2.3 billion unsecured revolving…

Researchers can now access and purchase nearly two million off-the-shelf antibodies, ELISA Kits, proteins and related reagents through Scientist.com’s award-winning…

DUBLIN–(BUSINESS WIRE)–The “Global Central Nervous System Therapeutic Market: Analysis By Disease, By Region, By Country (2019 Edition): Opportunities and Forecast…

– Financing to Advance Lead Development Program, INZ-701, through Clinical Proof of Concept in Two Indications – – Company Expands…

Dr. Reardon to lead strategic development of Ribometrix platform for novel RNA drug discovery Appointment of two vice presidents to…

HALIFAX, Nova Scotia–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24IMV&src=ctag" target="_blank"gt;$IMVlt;/agt; lt;a href="https://twitter.com/hashtag/AntibioticDeveloper?src=hash" target="_blank"gt;#AntibioticDeveloperlt;/agt;–Pharmaceutical company Appili Therapeutics Inc. (“Appili” or the “Company”) announced today that…

Acceptance for late breaking oral presentation underscores the oncology community’s interest in Namodenoson as a potential treatment for liver cancer…